Targeted Lipidomics Reveals Lipid Remodelling in Parkinson’s Disease
Murdoch University Research Portal · 2025-01-01
DOI: 10.60867/00000078 ↗At a glance
Journal article in Murdoch University Research Portal, published on 2025-01-01. Written by Jack Price.
Abstract (original language)
Parkinson’s Disease (PD) is a progressive, neurodegenerative condition that is increasing in prevalence globally. PD is marked by a loss of dopaminergic neurons in the brain, but system-wide metabolic disturbances are now understood to contribute to disease aetiogenesis. Importantly, whilst the clinical presentation of PD is highly heterogenous, a metabolic basis for stratification into different subtypes is lacking. As such, readily accessible biomarkers of PD that can give insight into disease status are highly sought after to address shortcomings in existing approaches that result in poor diagnostic accuracy, minimal treatment options, and a limited understanding of the disease process.
Subjects
Cite
APA
Price, J. (2025). Targeted Lipidomics Reveals Lipid Remodelling in Parkinson’s Disease. Murdoch University Research Portal. https://doi.org/10.60867/00000078
Vancouver
Price J. Targeted Lipidomics Reveals Lipid Remodelling in Parkinson’s Disease. Murdoch University Research Portal. 2025. doi:10.60867/00000078
BibTeX
@article{Price2025,
author = {Price, Jack},
title = {Targeted Lipidomics Reveals Lipid Remodelling in Parkinson’s Disease},
journal = {Murdoch University Research Portal},
year = {2025},
doi = {10.60867/00000078}
}
EUVIMED